TaiRx, Inc. (6580.TWO)
TWD 26.9
(0.94%)
TWD 26.9
(0.94%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 833.74 Million TWD | 56.12% |
| 2022 | 534.04 Million TWD | -24.42% |
| 2021 | 706.62 Million TWD | -15.61% |
| 2020 | 837.3 Million TWD | 71.11% |
| 2019 | 489.33 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 749.56 Million TWD | -10.1% |
| 2024 Q2 | 749.56 Million TWD | 0.0% |
| 2023 FY | 833.74 Million TWD | 56.12% |
| 2023 Q2 | 420.2 Million TWD | 0.0% |
| 2023 Q1 | 420.2 Million TWD | -21.32% |
| 2023 Q4 | 833.74 Million TWD | 0.0% |
| 2023 Q3 | 833.74 Million TWD | 98.42% |
| 2022 Q3 | 534.03 Million TWD | 0.0% |
| 2022 Q4 | 534.04 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -215.029% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 26.467% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -463.593% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 11.469% |
| NaviFUS Corp. | 490.53 Million TWD | -69.967% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 5.588% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 38.847% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 76.819% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1033.454% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 49.662% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -551.125% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 71.259% |
| AP Biosciences Inc | 890.75 Million TWD | 6.4% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 61.383% |
| RBC Bioscience Corporation | 753.79 Million TWD | -10.607% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 73.159% |
| EirGenix Inc. | 11.16 Billion TWD | 92.531% |
| Enimmune corporation | 604.82 Million TWD | -37.849% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -88.976% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 53.125% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -157.212% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 78.589% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 77.887% |
| TCI GENE Inc. | 1.16 Billion TWD | 28.492% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -120.357% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 94.573% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -103.225% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -176.963% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -51.936% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -110.09% |
| Neith Corporation | 192.15 Million TWD | -333.897% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 51.31% |
| VBI | 452.1 Million TWD | -84.415% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 59.837% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 29.112% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 28.108% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 72.983% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -57.564% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -183.028% |
| Visgeneer Inc. | 397.17 Million TWD | -109.919% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 28.211% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -45.47% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 31.979% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -25.428% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 20.632% |
| GlycoNex Incorporation | 1.55 Billion TWD | 46.307% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 90.223% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 37.484% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 78.913% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 69.247% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -11.378% |
| BiOptic Inc. | 613.77 Million TWD | -35.839% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 32.207% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 38.845% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -19.371% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 85.122% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 78.189% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -29.293% |
| Level Biotechnology Inc. | 822.67 Million TWD | -1.346% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 86.316% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 21.493% |
| Acepodia, Inc. | 6.81 Billion TWD | 87.772% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 78.211% |